Our results are in line with previous findings [21, 61] of decreasing levels of soluble ICAM-1 with vitamin D treatment in patients with CKD, believed to be a sign of a less pro-atherosclerotic endothelium. The gene discussed is ICAM1; the disease is chronic kidney disease.